Episode Details

Back to Episodes

Episode 4. Measurable Residual Disease in AML

Episode 5 Published 3 years, 9 months ago

Description

2021 European LeukemiaNET MRD Working Party Consensus Guidelines: https://pubmed.ncbi.nlm.nih.gov/34724563/

Pre-MEASURE Study ASCO 2022: https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.7006

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.